Invention Grant
- Patent Title: Vaccination against diabetes, obesity and complications thereof
-
Application No.: US17084853Application Date: 2020-10-30
-
Publication No.: US11623003B2Publication Date: 2023-04-11
- Inventor: Vincent Blasco-Baque , Lucile Garidou , Rémy Burcelin
- Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , UNIVERSITE PAUL SABATIER TOULOUSE III , CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Applicant Address: FR Paris; FR Toulouse; FR Toulouse
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE PAUL SABATIER TOULOUSE III,CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE PAUL SABATIER TOULOUSE III,CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
- Current Assignee Address: FR Paris; FR Toulouse; FR Toulouse
- Agency: WCF IP
- Priority: EP15307004 20151215
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/114 ; A61P3/10 ; A61K39/00
Abstract:
Vaccines for preventing or treating diabetes, obesity and complications thereof are provided. The vaccines comprise at least one active agent such as attenuated Porphyromonas gingivalis, inactivated Porphyromonas gingivalis, a subunit of Porphyromonas gingivalis, a recombinant or isolated immunogenic polypeptide or peptide from Porphyromonas gingivalis or a cDNA from Porphyromonas gingivalis.
Public/Granted literature
- US20210069313A1 VACCINATION AGAINST DIABETES, OBESITY AND COMPLICATIONS THEREOF Public/Granted day:2021-03-11
Information query
